These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 21404590)

  • 1. [Role of mycolactone in the nerve damage of Buruli ulcer (Mycobacterium ulcerans infection)].
    En J; Ishii N; Goto M
    Nihon Hansenbyo Gakkai Zasshi; 2011 Feb; 80(1):5-10. PubMed ID: 21404590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycolactone is responsible for the painlessness of Mycobacterium ulcerans infection (buruli ulcer) in a murine study.
    En J; Goto M; Nakanaga K; Higashi M; Ishii N; Saito H; Yonezawa S; Hamada H; Small PL
    Infect Immun; 2008 May; 76(5):2002-7. PubMed ID: 18316387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycolactone cytotoxicity in Schwann cells could explain nerve damage in Buruli ulcer.
    En J; Kitamoto S; Kawashima A; Yonezawa S; Kishi Y; Ishii N; Goto M
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005834. PubMed ID: 28783752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nerve damage in Mycobacterium ulcerans-infected mice: probable cause of painlessness in buruli ulcer.
    Goto M; Nakanaga K; Aung T; Hamada T; Yamada N; Nomoto M; Kitajima S; Ishii N; Yonezawa S; Saito H
    Am J Pathol; 2006 Mar; 168(3):805-11. PubMed ID: 16507896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycolactone gene expression is controlled by strong SigA-like promoters with utility in studies of Mycobacterium ulcerans and buruli ulcer.
    Tobias NJ; Seemann T; Pidot SJ; Porter JL; Marsollier L; Marion E; Letournel F; Zakir T; Azuolas J; Wallace JR; Hong H; Davies JK; Howden BP; Johnson PD; Jenkin GA; Stinear TP
    PLoS Negl Trop Dis; 2009 Nov; 3(11):e553. PubMed ID: 19936295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.
    Fraga AG; Martins TG; Torrado E; Huygen K; Portaels F; Silva MT; Castro AG; Pedrosa J
    PLoS One; 2012; 7(3):e33406. PubMed ID: 22413022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced Synthesis of Mycolactone Restores the Pathogenesis of
    Strong E; Hart B; Wang J; Orozco MG; Lee S
    Front Immunol; 2022; 13():750643. PubMed ID: 35401531
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer.
    Silva MT; Portaels F; Pedrosa J
    Lancet Infect Dis; 2009 Nov; 9(11):699-710. PubMed ID: 19850228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited repair and structural damages displayed by skeletal muscles loaded with mycolactone.
    Houngbédji GM; Côté CH; Small PL; Frenette J
    Microbes Infect; 2009 Feb; 11(2):238-44. PubMed ID: 19114122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs.
    Hong H; Coutanceau E; Leclerc M; Caleechurn L; Leadlay PF; Demangel C
    PLoS Negl Trop Dis; 2008; 2(10):e325. PubMed ID: 18941518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemistry of mycolactones, the causative toxins of Buruli ulcer.
    Kishi Y
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6703-8. PubMed ID: 21383136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycolactone-mediated neurite degeneration and functional effects in cultured human and rat DRG neurons: Mechanisms underlying hypoalgesia in Buruli ulcer.
    Anand U; Sinisi M; Fox M; MacQuillan A; Quick T; Korchev Y; Bountra C; McCarthy T; Anand P
    Mol Pain; 2016; 12():. PubMed ID: 27325560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo.
    Adusumilli S; Mve-Obiang A; Sparer T; Meyers W; Hayman J; Small PL
    Cell Microbiol; 2005 Sep; 7(9):1295-304. PubMed ID: 16098217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of a dewaxed whole-cell vaccine against Mycobacterium ulcerans infection in mice.
    Watanabe M; Nakamura H; Nabekura R; Shinoda N; Suzuki E; Saito H
    Vaccine; 2015 May; 33(19):2232-2239. PubMed ID: 25825332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease.
    Sarfo FS; Phillips R; Wansbrough-Jones M; Simmonds RE
    Cell Microbiol; 2016 Jan; 18(1):17-29. PubMed ID: 26572803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Mycobacterium species for the presence of a macrolide toxin, mycolactone.
    Daniel AK; Lee RE; Portaels F; Small PL
    Infect Immun; 2004 Jan; 72(1):123-32. PubMed ID: 14688089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local Cellular Immune Responses and Pathogenesis of Buruli Ulcer Lesions in the Experimental Mycobacterium Ulcerans Pig Infection Model.
    Bolz M; Ruggli N; Borel N; Pluschke G; Ruf MT
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004678. PubMed ID: 27128097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of wild-type and mycolactone-negative mutant Mycobacterium ulcerans on skeletal muscle: IGF-1 protects against mycolactone-induced muscle catabolism.
    Dufresne SS; Frenette J
    Am J Physiol Regul Integr Comp Physiol; 2013 May; 304(9):R753-62. PubMed ID: 23485865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview: Mycolactone , the Macrolide Toxin of Mycobacterium ulcerans.
    Röltgen K; Pluschke G
    Methods Mol Biol; 2022; 2387():105-108. PubMed ID: 34643906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin-specific antibodies neutralizing mycolactone toxin during the spontaneous healing of
    Foulon M; Pouchin A; Manry J; Khater F; Robbe-Saule M; Durand A; Esnault L; Delneste Y; Jeannin P; Saint-André JP; Croué A; Altare F; Abel L; Alcaïs A; Marion E
    Sci Adv; 2020 Feb; 6(9):eaax7781. PubMed ID: 32133396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.